Background-The British Thoracic Society report on the diagnosis and treatment of the sleep apnoea/hypopnoea syndrome (SAHS) suggests that, ifthe pulse oximetry baseline oxygen saturation is above 90%,
then 15 4%/o oxygen desaturationslhour in bed will diagnose SAHS requiring treatment. The diagnostic outcome of applying these guidelines has been studied. Methods-One hundred patients referred to a district general hospital sleep clinic were recruited. After initial clinical assessment, overnight pulse oximetry measurements were performed, followed by full polysomnography at the regional laboratory.
Results -Sixty nine patients underwent both pulse oximetry and polysomnography. All 10 patients with more than 15 4% desaturations/hour on pulse oxinetry had SAHS confirmed on polysomnography (specificity= 100%). Twenty two patients with SAHS were misdiagnosed using pulse oximetry alone (sensitivity= 31%). These patients had low apnoea scores but high hypopnoea scores.
Conclusions -The BTS pulse oximetry criteria are highly specific when positive (specificity= 100%), but may miss patients with the SAHS who have hypopnoeic episodes which cause arousal but not significant oxygen desaturation (sensitivity = 31%). It and there are at least 15 4% dips in oxygen saturation per hour in bed. The original guidelines suggested that oximetry studies in a district general hospital should take place in a quiet supervised room; however, the practice in our hospital and most others is for the patient to take an oximeter home to record overnight oximetry. It is in this context that it is now timely to assess these guidelines.
In this prospective study we have examined 100 consecutive patients referred to a sleep clinic in a district general hospital (DGH) for suspected SAHS using the BTS pulse oximetry criteria to make a diagnosis. These patients subsequently had full polysomnography at the regional sleep centre to establish whether the BTS guidelines were able to discriminate between patients with and without the SAHS. 
Methods

Results
Of 100 patients entered into the trial 31 did not complete the protocol. Seven were discovered to have hypothyroidism on initial investigation, five had other medical conditions (three asthmatics, one myopathy, and one cardiac failure), seven had missing or incomplete data; 11 failed to attend all appointments, and one patient's overnight hypoxia was considered too severe for treatment to be delayed by awaiting polysomnography. Sixty nine patients (57 men) had both pulse oximetry at the hospital and polysomnography at the regional sleep laboratory. Demographic data are shown in the Ohmeda 3700 which prints out the lowest value in each 12 second period. Our study used the Minolta Pulsox-7 which prints the measured oxygen saturation at 10 second intervals. Pulse oximetry is far from perfect and a low threshold for diagnosis will miss fewer patients with SAHS and give a high sensitivity at the expense of too many false positives and a low specificity. A higher oximetry threshold eliminates most false positives giving a high specificity but, as one would expect, the number of false negative results increases, resulting in a low sensitivity.
Our study shows how the BTS guidelines for the diagnosis of the SAHS are used with home oximetry by a district general hospital. It shows that, using the recommended criteria, there is high specificity but a large number of false negatives. Many of these patients in the false negative group were treated successfully with nasal CPAP. These findings are in close agreement with studies from tertiary referral centres when the same oximetry and polysomnography criteria are used.'3 '4 We have also shown that the reason for the low sensitivity is that, whilst pulse oximetry is able to detect most episodes of apnoea, it tends to miss hypopnoeic episodes. This is because periods ofhypopnoea, although causing clinically significant arousal and thus symptoms of daytime somnolence, are not always associated with falls in oxygen saturation. Of note is the lower body mass index in the false negative group compared with the true positive group. It has been suggested that a lower functional residual capacity in more obese patients may cause greater desaturation which may explain some of the difference in oximetry between the two groups. There is a danger that if one relies solely on pulse oximetry, many ofthe affected population will be missed. Untreated disease increases the risk of poor work performance, road traffic accidents, cardiorespiratory failure, stroke, and early death. '9 How do these results translate into everyday clinical practice? The first point to note is that only just over two thirds of patients originally referred underwent both oximetry and polysomnography. There was a large number of non-attenders and incomplete data sets which we feel reflects both the difficulties for patients travelling 50 miles to the regional centre and the realities of NHS practice. Seven patients were found to have hypothyroidism at initial assessent and five had other medical conditions. This emphasises the need for full medical assessment at the initial consultation. The positive predictive value of pulse oximetry using the BTS criteria of >15 4% oxygen desaturations per hour was 100% and, as such, obviates the need to perform polysomnography. In these cases treatment with NCPAP is started after appropriate investigations and lifestyle advice. The predictive value of a negative pulse oximetry test is only 63% -that is, over one third of patients in this group may have the SAHS. However, because of the low sensitivity of negative oximetry, many of these patients will require polysomnography to confirm or refute SAHS depending on the likelihood of SAHS before the test.
Can we do better using oximetry alone? By lowering the oximetry threshold we could expect to miss fewer patients with the SAHS, accepting a higher number of false positives. Douglas has shown that, even if only five 4% desaturations per hour are used to make a pulse oximetry diagnosis of SAHS, a number of true cases of SAHS are missed.'6 Gyulay et al found that the cumulative time spent below 90% saturation was a more sensitive marker for sleep apnoea than counting repetitive desaturations, and that by combining the two measures oximetry was a better, though still imperfect, screening test."
Combining pulse oximetry with other measurements seems to be the way forward if we wish to avoid performing full polysomnography in all patients. There has been some success in recording snoring sounds and matching these to reductions in oxygen saturation. Using a respiratory disturbance index of > 15, sensitivity and specificity of 87% and 96% have been reported.6 Oximetry and respiratory movements using a static charge sensitive bed produced up to 100% sensitivity and 67% specificity, depending on the criteria evaluated. 7 We have demonstrated the use of the BTS criteria for pulse oximetry for the diagnosis of SAHS in a district general hospital with a sleep clinic. By comparing the results with full polysomnography it is clear that positive pulse oximetry has a high predictive value and, in practical terms, is diagnostic of SAHS. However, there is a large group of patients with negative pulse oximetry, and these cases require further investigation if they have symptoms of daytime somnolence. The BTS guidelines are very useful when positive and may be used to avoid polysomnography and justify treatment.
In the remaining group it should be made clear that <15 4% desaturations/hour does not exclude significant SAHS. At the level of the district general hospital patients with >15 4% desaturations/hour should be treated, while those with <15 4% desaturations/hour and symptoms of daytime somnolence should be referred to a recognised sleep centre for polysomnography or multichannel recording if equipment and expertise is not available locally. 
